All Stories

  1. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry
  2. Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography
  3. Metabolomic Perspectives in Antiblastic Cardiotoxicity and Cardioprotection
  4. Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM‐HF trial, ESC guidelines, and real world
  5. Acute heart failure congestion and perfusion status – impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure Long‐Term Registry
  6. IGENDA protocol
  7. Women-specific predictors of cardiovascular disease risk - new paradigms
  8. Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state
  9. Gender differences in cardiology
  10. Chemotherapy-induced cardiotoxicity
  11. Metabolomic Approach to Redox and Nitrosative Reactions in Cardiovascular Diseases
  12. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry
  13. The need of a gender-corrected evidence based medicine
  14. Early right ventricular dysfunction in highly selected (totally free from cardiovascular risk factors and other comorbidities) human immunodeficiency virus patients: A pilot study with advanced echocardiography
  15. Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects
  16. Looking for the gender equality
  17. Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease
  18. Distinctive Metabolomic Fingerprint in Scleroderma Patients with Pulmonary Arterial Hypertension
  19. Modelling Chemotherapy-induced Cardiotoxicity by Human Pluripotent Stem Cells
  20. Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine
  21. Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy
  22. "Omics" sciences in antiblastic cardiotoxicity and cardioprotection
  23. Cardiotoxicity from anthracycline and cardioprotection in paediatric cancer patients
  24. Metabolomic applications in cardiology
  25. A New Type of Physical Activity from an Ancient Tradition: The Sardinian Folk Dance “Ballu Sardu”
  26. Metabolic changes related to different degrees of heart failure
  27. Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection
  28. Cardioprotection by gene therapy
  29. Endodontic Infection and Endothelial Dysfunction Are Associated with Different Mechanisms in Men and Women
  30. Heart rate variability shows different cardiovascular modulation in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype
  31. Effects of an Aquatic-Based Exercise Program to Improve Cardiometabolic Profile, Quality of Life, and Physical Activity Levels in Men With Type 2 Diabetes Mellitus
  32. Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance
  33. Sex differences in congenital heart defects and genetically induced arrhythmias
  34. Altered Transmural Contractility in Postmenopausal Women Affected by Cardiac Syndrome X
  35. Ankle–Brachial Index and Its Link to Automated Carotid Ultrasound Measurement of Intima–Media Thickness Variability in 500 Japanese Coronary Artery Disease Patients
  36. Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients
  37. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry
  38. Subclinical contractility impairment in HIV-infected patients: Dependence on the class of antiretroviral drugs
  39. Relationship between high values of HOMA-IR and cardiovascular response to metformin
  40. Association of automated carotid IMT measurement and HbA1c in Japanese patients with coronary artery disease
  41. Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects
  42. Metabolomic approach to foetal and neonatal heart
  43. Could ADMA levels in young adults born preterm predict an early endothelial dysfunction?
  44. Cardiopulmonary and endothelial effects of metformin treatment in an insulin resistant population
  45. Association of Endodontic Infection with Detection of an Initial Lesion to the Cardiovascular System
  46. A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics
  47. Metabolomics
  48. Long-term protective effects of the angiotensin receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress and myocardial dysfunction
  49. Inverted Takotsubo Cardiomyopathy Induced by Dobutamine Stress Echocardiography with Atypical Presentation
  50. Cardiovascular modulation during vagus nerve stimulation therapy in patients with refractory epilepsy
  51. Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment
  52. Gender determinants of cardiovascular risk factors and diseases
  53. Echocardiographic accidental finding of asymptomatic cardiac and pulmonary embolism caused by cement leakage after percutaneous vertebroplasty
  54. Cardiac effects of l-thyroxine administration in borderline hypothyroidism
  55. Effect of Hormone Therapy on Exercise Capacity in Early Postmenopausal Women
  56. Early Epirubicin-Induced Myocardial Dysfunction Revealed by Serial Tissue Doppler Echocardiography: Correlation with Inflammatory and Oxidative Stress Markers
  57. Impairment of physical exercise capacity in healthy postmenopausal women
  58. Cardiac function in borderline hypothyroidism: a study by pulsed wave tissue Doppler imaging
  59. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk